Nice summary of our recent paper. And green viruses make everything more fun. “A hybrid virus to study HIV-1 in mice” elifesciences.org/digests/49875/…

It’s time...

Hi Mayor Eric Adams — you can't say or even pretend that you care about the welfare of bike riders if you don't use your authority to stop horrible shit like this. gothamist.com/news/graphic-v…

If Mayor Eric Adams is serious about encouraging New Yorkers to bike and walk, he has the tools to make this a viable option. Sign our petition to push the City to roll out some urgent improvements to our bike infrastructure. campaigns.transalt.org/petition/tell-…

We are still looking for technicians. If you are interested, please send me an email. Currently, we are looking for applicants who are already in the New York City area and who can commit to two years in the lab. We need help for both influenza and SARS-CoV-2 projects.

SCIENCE PROFESSIONALS!!!!!! If you are a Black scientist, or a scientist of color, willing to do virtual talks for grade school kids, could you drop your information (field of study, email) in this thread? There’s a great need for us!!!!! Thank you!

Our latest on SARS-CoV-2 neutralization with Theodora, the Rice lab and Nussenzweig_LAB now in press.

Amazing ride tonight with ⁦Street Riders NYC⁩ #BlackLivesMattter

Please circulate to anyone interested. We are searching for a research tech/lab manager to join us at Harvard Medical School and Boston Children's. An opportunity for lots of responsibility and exciting science. Please contact me via DM or kaganlab.com for more information.

Covid vaccines can't protect millions of Americans who are immunocompromised and whose bodies cannot learn to deploy immune fighters against the virus. But researchers are testing one therapy that may help. nyti.ms/32i0QPh

Very excited to share RenBio’s news on completion of our Series A and license for a novel bispecific antibody targeting SARS-CoV-2 #COVID19 #NYCBiotech #antibody prnewswire.com/news-releases/…

The famed AIDS researcher David Ho started off the Covid-19 pandemic working to develop an antibody against the SARS-CoV-2 virus, but now he’s behind a new biotech that’s taking a slightly different approach to fight the disease. endpts.com/hiv-researcher…

“Our goal is to be in the clinic by the end of this year,” said Neal Padte, Ph.D., chief operating and development officer fiercebiotech.com/biotech/renbio…

Great piece in Endpoints News on the history of broadly neutralizing #antibodies for infectious diseases, including their importance in the #COVID19 pandemic. endpts.com/inside-the-30-…

RenBio is hiring! Come join a great team in NYC working on new technologies for delivering antiviral #antibodies linkedin.com/jobs/view/2738… #biotech

Come join our #RenBio team Seeking highly motivated & goal-oriented Research Associate to be part of developing nucleic acid-based platform technology for next-gen treatments for oncology, inflammatory, and infectious disease. bit.ly/3msdLIS #HiringNow #jobopening #NYC

Excited to announce that #RenBio is one of eight biotechs awarded a grant from #EmpireStateDevelopment's NY State Biodefense Commercialization Fund for development of our next-gen, nucleic acid-based MYO Technology platform. #NYCBiotech #infectiousdiseases shorturl.at/syCJS

We are here at 4th World Congress on Electroporation in Copenhagen. If you are here as well don’t forget to be at Session P31 where Andrew Cameron will be talking about our MYO Technology. #WCE2022

Excited to announce that we have been awarded 2 new grants from DARPA Vanderbilt University & Empire State Development for development of our platform to fight infectious disease outbreaks. #nycbiotech prnewswire.com/news-releases/…

Thanks for having me on - it was a pleasure!